EP2089423
Sértæk fjölvakaeiningabóluefni gegn ónæmisvökum
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
23.9.2007EP published:
26.10.2016EP application number:
07827143.4
EP translation filed:
12.1.2017Grant published:
15.2.2017EPO information:
European Patent Register
Max expiry date:
22.9.2027Expiry date:
22.9.2024
Title:
ANTIGEN SPECIFIC MULTI EPITOPE VACCINES
Timeline
Today
23.9.2007EP application
26.10.2016EP Publication
12.1.2017Translation submitted
15.2.2017Registration published
22.9.2024Expires
Owner
Name:
Vaxil Biotherapeutics Ltd.Address:
Building 13A Weizmann Science Park, 76120, Rehovot, IL
Inventor
Name:
CARMON, LiorAddress:
Tel Aviv, IL
Agent
Name:
Novagraaf BrevetsAddress:
Bâtiment O2, 2 rue Sarah Bernhardt CS90017, FR
Priority
Number:
846087 PDate:
21.9.2006Country:
US
Classification
Categories:
C07K 14/47, C07K 14/705, A61K 39/00, A61P 35/00, C07K 14/74
Annual fees
Number
Paid
Expires
Payer
Number: 11
Paid: 11.9.2017
Expires: 22.9.2018
Payer: Árnason Faktor
Number: 12
Paid: 24.9.2018
Expires: 22.9.2019
Payer: Árnason Faktor
Number: 13
Paid: 27.8.2019
Expires: 22.9.2020
Payer: Árnason Faktor
Number: 14
Paid: 24.9.2020
Expires: 22.9.2021
Payer: Árnason Faktor ehf.
Number: 15
Paid: 7.9.2021
Expires: 22.9.2022
Payer: Árnason Faktor ehf.
Number: 16
Paid: 27.9.2022
Expires: 22.9.2023
Payer: Árnason Faktor ehf.
Number: 17
Paid: 25.9.2023
Expires: 22.9.2024
Payer: Árnason Faktor ehf.